(Q42247379)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

title

IFNL3 mediates interaction between innate immune cells: Implications for hepatitis C virus pathogenesis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Golo Ahlenstiel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Vijay Suppiah

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

12

Jacob George

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Kate S O'Connor

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Stephen Schibeci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Adrian Ong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David van der Poorten

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Mark W Douglas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Martin D Weltman

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Graeme J Stewart

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Christopher Liddle

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

David R Booth

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

17 September 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

page(s)

598-605

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24045339%20AND%20SRC:MED&resulttype=core&format=json

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

22 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Impact of IL28B genotype on the early and sustained virologic response in treatment-naïve patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IL28B polymorphisms determine early viral kinetics and treatment outcome in patients receiving peginterferon/ribavirin for chronic hepatitis C genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IL-28, IL-29 and their class II cytokine receptor IL-28R

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Interferon-lambda: a new addition to an old family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Lambda interferon inhibits hepatitis B and C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Interferon lambda as a potential new therapeutic for hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Development of a standardized protocol for reproducible generation of matured monocyte-derived dendritic cells suitable for clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Interferon-lambda-treated dendritic cells specifically induce proliferation of FOXP3-expressing suppressor T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Alpha and lambda interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

IFN-lambda1 (IL-29) inhibits GATA3 expression and suppresses Th2 responses in human naive and memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

Interferon type I gene expression in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385

A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753425913503385